HLB Life Science Co., Ltd. (KOSDAQ:067630)
South Korea flag South Korea · Delayed Price · Currency is KRW
4,295.00
-5.00 (-0.12%)
Apr 29, 2026, 3:30 PM KST

HLB Life Science Income Statement

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2016
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 2020 - 2016
Operating Revenue
45,75232,77197,99099,59153,494
Upgrade
Other Revenue
---00
Upgrade
Revenue
45,75232,77197,99099,59153,494
Upgrade
Revenue Growth (YoY)
39.61%-66.56%-1.61%86.17%-41.73%
Upgrade
Cost of Revenue
46,47436,40598,915102,81359,155
Upgrade
Gross Profit
-721.6-3,634-925.04-3,222-5,661
Upgrade
Selling, General & Admin
13,85512,45815,22610,8398,247
Upgrade
Research & Development
4,6975,1775,4544,3493,846
Upgrade
Amortization of Goodwill & Intangibles
454.32182.4990.25591.418.01
Upgrade
Other Operating Expenses
382.1351.11279192.67113.46
Upgrade
Operating Expenses
20,31416,35024,56816,72812,668
Upgrade
Operating Income
-21,035-19,984-25,493-19,950-18,329
Upgrade
Interest Expense
-11,744-16,798-21,650-9,870-1,256
Upgrade
Interest & Investment Income
2,2411,3561,2881,203512.76
Upgrade
Earnings From Equity Investments
2,4061,354-2,5372,602-
Upgrade
Currency Exchange Gain (Loss)
-169.5121.23-93.2233.77-4.05
Upgrade
Other Non Operating Income (Expenses)
372.86101.69469.76-2,664-60.63
Upgrade
EBT Excluding Unusual Items
-27,928-33,848-48,015-28,646-19,137
Upgrade
Gain (Loss) on Sale of Investments
-63,32961,65281,336-20,548-21,296
Upgrade
Gain (Loss) on Sale of Assets
-3,23610.31-304.963,157594.55
Upgrade
Asset Writedown
-6,073-24,162-37,553-14,802-13,786
Upgrade
Other Unusual Items
---1,966--
Upgrade
Pretax Income
-100,5663,652-6,503-60,839-53,624
Upgrade
Income Tax Expense
-666.74-3,058-590.06-6,479-4,333
Upgrade
Earnings From Continuing Operations
-99,8996,710-5,913-54,360-49,292
Upgrade
Earnings From Discontinued Operations
-44.95-503.11---
Upgrade
Net Income to Company
-99,9446,207-5,913-54,360-49,292
Upgrade
Minority Interest in Earnings
149.97-68.89-70.3582.24139.89
Upgrade
Net Income
-99,7946,138-5,983-54,277-49,152
Upgrade
Net Income to Common
-99,7946,138-5,983-54,277-49,152
Upgrade
Shares Outstanding (Basic)
12211210210199
Upgrade
Shares Outstanding (Diluted)
12211210210199
Upgrade
Shares Change (YoY)
9.19%9.65%0.80%1.64%0.34%
Upgrade
EPS (Basic)
-819.0055.00-58.79-537.56-494.76
Upgrade
EPS (Diluted)
-819.0055.00-59.00-537.56-494.76
Upgrade
Free Cash Flow
-48,515-59,301-30,634-40,420-16,505
Upgrade
Free Cash Flow Per Share
-398.16-531.38-300.99-400.32-166.14
Upgrade
Gross Margin
-1.58%-11.09%-0.94%-3.23%-10.58%
Upgrade
Operating Margin
-45.98%-60.98%-26.02%-20.03%-34.26%
Upgrade
Profit Margin
-218.12%18.73%-6.11%-54.50%-91.88%
Upgrade
Free Cash Flow Margin
-106.04%-180.96%-31.26%-40.59%-30.85%
Upgrade
EBITDA
-15,788-14,083-17,797-14,727-15,845
Upgrade
EBITDA Margin
-34.51%-42.97%-18.16%-14.79%-29.62%
Upgrade
D&A For EBITDA
5,2475,9017,6965,2232,484
Upgrade
EBIT
-21,035-19,984-25,493-19,950-18,329
Upgrade
EBIT Margin
-45.98%-60.98%-26.02%-20.03%-34.26%
Upgrade
Advertising Expenses
70.4996.93157.8669.1334.92
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.